| Identity |
| HGNC | KIAA1618 |
| Location | 17q25 |
| DNA/RNA |
| Transcription | alternate spicing; 5185 and 5332 bp cDNA |
| Protein |
| Description | 1550 and 1599 amino acids if the sequence is complete; putative zinc finger in the N term, and AraC motif in the C term |
| Implicated in |
| Entity | Anaplasic large cell lymphoma (ALCL) with t(2;17)(p23;q25) --> ALK- ALO17 |
| Disease | ALCL are high grade non Hodgkin lymphomas; ALK+ ALCL are ALCL where ALK is involved in a fusion gene; ALK+ ALCL represent 50 to 60 % of ALCL cases (they are CD30+, ALK+;); belong to the "cytoplasmic ALK+" subset. |
| Prognosis | Althouth presenting as a high grade tumour, a 80% five yr survival is associated with this anomaly |
| Hybrid/Mutated Gene | 5' ALO17 - 3' ALK |
| Abnormal Protein | NH2 ALO17 - COOH ALK |
| External links |
| Bibliography |
| Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor. |
| Cools J, Wlodarska I, Somers R, Mentens N, Pedeutour F, Maes B, De Wolf-Peeters C, Pauwels P, Hagemeijer A, Marynen P |
| Genes, chromosomes & cancer. 2002 ; 34 (4) : 354-362. |
| PMID 12112524 |
| REVIEW articles | automatic search in PubMed |
| Last year publications | automatic search in PubMed |
| Contributor(s) |
| Written | 08-2003 | Jean-Loup Huret, Sylvie Senon |
| Citation |
| This paper should be referenced as such : |
| Huret JL, Senon S . ALO17 (ALK lymphoma oligomerization partner on chromosome 17). Atlas Genet Cytogenet Oncol Haematol. August 2003 . URL : http://AtlasGeneticsOncology.org/Genes/ALO17ID480.html |
| © Atlas of Genetics and Cytogenetics in Oncology and Haematology | indexed on : Mon Aug 11 21:12:04 2008 |
For comments and suggestions or contributions, please contact us